Manufacturing & Packaging

Organization’s PAI portfolio boosts drug R&D, process development for pharma manufacturers

Project is centered around drug substance manufacturing

P4 is partially operational in under two years

Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization

A conversation with dangerous goods expert Jay Johnson

Biopharma company's 100,000 square-foot California center will house its blood cancer treatments

Designation is powered by CDMO’s sustainability focus

Microbial production site’s manufacturing capacity to increase by 70% upon completion

Commercial GMP facility is first of its kind in the Emerald Isle, the company says

With deal, drug wholesaler grows its biopharma services platform

Supply chain shortages mean short notice changes to products—is your labeling system missing the key ingredients?

Acquisition helps grow its CDMO capabilities

Financial commitment expected to benefit capabilities of single-use assemblies

Law firm to feature life sciences practice in New Jersey and Philadelphia

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Allows CDMO to enhance its therapeutic and vaccine offerings

Will feature additional cell and gene therapy capacity

Collaboration expected to accelerate the bionnovative drug R&D process

Massachusetts facility will support biologics developers in the New England area

Massachusetts facility will be dedicated to offering viral vector production services

Company’s Conroe location will serve as HQ

CDMO’s 76,000 square-foot manufacturing center will be commercial ready

Track-and-trace provider will be incorporating fingerprinting tech into its line

CDMO filling capacity now exceeds 50 million units yearly

Ultra low-temperature freezers continue to change the game in cold chain

Site expected to boost the CDMO’s global drug production capabilities

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity

Division will operate under SCHOTT Pharma AG & Co. KGaA

CDMO’s new project focuses on addressing needs in oncology sector